$CRNX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Crinetics Pharmaceuticals, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Crinetics Pharmaceuticals, Inc.. Get notifications about new insider transactions in Crinetics Pharmaceuticals, Inc. for free.

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 02 2021	CRNX	Crinetics Pharmace ...	Krasner Alan Seth	Chief Medical Offic ...	Option Exercise	A	15.29	125,000	1,911,250	125,000
Mar 02 2021	CRNX	Crinetics Pharmace ...	Wilson Marc	CFO and Secretary	Option Exercise	A	15.29	114,000	1,743,060	114,000
Mar 02 2021	CRNX	Crinetics Pharmace ...	Struthers Richard Scott	President & CEO	Option Exercise	A	15.29	294,000	4,495,260	294,000
Dec 04 2020	CRNX	Crinetics Pharmace ...	Struthers Richard Scott	President & CEO	Buy	P	13.10	4,000	52,400	4,000	0 to 4 K
Dec 04 2020	CRNX	Crinetics Pharmace ...	Struthers Richard Scott	President & CEO	Buy	P	12.60	1,000	12,600	1,000	0 to 1,000
Sep 03 2020	CRNX	Crinetics Pharmace ...	Bedrosian Camille L	Director	Option Exercise	A	16.08	25,000	402,000	25,000
Jul 17 2020	CRNX	Crinetics Pharmace ...	Struthers Richard Scott	President & CEO	Sell	S	14.46	17,500	253,108	890,805	908.3 K to 890.8 K (-1.93 %)
Jul 17 2020	CRNX	Crinetics Pharmace ...	Struthers Richard Scott	President & CEO	Sell	S	15.30	17,500	267,722	908,305	925.8 K to 908.3 K (-1.89 %)
Jun 22 2020	CRNX	Crinetics Pharmace ...	Fust Matthew K	Director	Option Exercise	A	23.23	12,500	290,375	12,500
Jun 22 2020	CRNX	Crinetics Pharmace ...	Kaldor Stephen W	Director	Option Exercise	A	23.23	12,500	290,375	12,500
Jun 22 2020	CRNX	Crinetics Pharmace ...	Nichols Weston	Director	Option Exercise	A	23.23	12,500	290,375	12,500
Jun 22 2020	CRNX	Crinetics Pharmace ...	Okey Stephanie	Director	Option Exercise	A	23.23	12,500	290,375	12,500
Jun 22 2020	CRNX	Crinetics Pharmace ...	WIERENGA WENDALL	Director	Option Exercise	A	23.23	12,500	290,375	12,500
Apr 29 2020	CRNX	Crinetics Pharmace ...	WIERENGA WENDALL	Director	Option Exercise	M	0.73	25,329	18,490	12,500
Apr 29 2020	CRNX	Crinetics Pharmace ...	WIERENGA WENDALL	Director	Buy	M	0.73	25,329	18,490	99,846	74.5 K to 99.8 K (+33.99 %)
Apr 20 2020	CRNX	Crinetics Pharmace ...	PERCEPTIVE ADVISORS LLC	10% Owner	Buy	P	14.00	1,071,428	14,999,992	3,659,381	2.6 M to 3.7 M (+41.40 %)
Apr 17 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	15.40	10,265	158,081	298,625	308.9 K to 298.6 K (-3.32 %)
Apr 17 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	15.40	74,333	1,144,728	2,162,587	2.2 M to 2.2 M (-3.32 %)
Apr 17 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	15.20	3,663	55,678	308,890	312.6 K to 308.9 K (-1.17 %)
Apr 17 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	15.20	26,527	403,210	2,236,920	2.3 M to 2.2 M (-1.17 %)
Apr 17 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	15.50	26,185	405,868	312,553	338.7 K to 312.6 K (-7.73 %)
Apr 17 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	15.50	189,625	2,939,188	2,263,447	2.5 M to 2.3 M (-7.73 %)
Apr 07 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	14.20	742	10,536	338,738	339.5 K to 338.7 K (-0.22 %)
Apr 07 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	14.20	5,373	76,297	2,453,072	2.5 M to 2.5 M (-0.22 %)
Apr 07 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	13.80	36,400	502,320	339,480	375.9 K to 339.5 K (-9.68 %)
Apr 07 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	13.80	263,600	3,637,680	2,458,445	2.7 M to 2.5 M (-9.68 %)
Mar 11 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	19.50	133	2,594	168,165	168.3 K to 168.2 K (-0.08 %)
Mar 11 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	19.50	48	936	375,880	375.9 K to 375.9 K (-0.01 %)
Mar 11 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	19.50	347	6,767	2,722,045	2.7 M to 2.7 M (-0.01 %)
Feb 26 2020	CRNX	Crinetics Pharmace ...	Krasner Alan Seth	Chief Medical Offic ...	Option Exercise	A	22.61	45,000	1,017,450	45,000
Feb 26 2020	CRNX	Crinetics Pharmace ...	Struthers Richard Scott	President & CEO	Option Exercise	A	22.61	200,000	4,522,000	200,000
Feb 11 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	21.40	5,904	126,346	168,298	174.2 K to 168.3 K (-3.39 %)
Feb 11 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	21.40	200	4,280	375,928	376.1 K to 375.9 K (-0.05 %)
Feb 11 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	21.40	1,451	31,051	2,722,392	2.7 M to 2.7 M (-0.05 %)
Feb 11 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.00	4,614	101,508	174,202	178.8 K to 174.2 K (-2.58 %)
Feb 11 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.00	157	3,454	376,128	376.3 K to 376.1 K (-0.04 %)
Feb 11 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.00	1,134	24,948	2,723,843	2.7 M to 2.7 M (-0.04 %)
Feb 06 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.80	10,519	239,833	178,816	189.3 K to 178.8 K (-5.56 %)
Feb 06 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.80	357	8,140	376,285	376.6 K to 376.3 K (-0.09 %)
Feb 06 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.80	2,584	58,915	2,724,977	2.7 M to 2.7 M (-0.09 %)
Jan 31 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	21.70	4,220	91,574	189,335	193.6 K to 189.3 K (-2.18 %)
Jan 31 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	21.70	143	3,103	376,642	376.8 K to 376.6 K (-0.04 %)
Jan 31 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	21.70	1,037	22,503	2,727,561	2.7 M to 2.7 M (-0.04 %)
Jan 31 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.10	5,940	131,274	193,555	199.5 K to 193.6 K (-2.98 %)
Jan 31 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.10	201	4,442	376,785	377 K to 376.8 K (-0.05 %)
Jan 31 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.10	1,459	32,244	2,728,598	2.7 M to 2.7 M (-0.05 %)
Jan 31 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.20	10,878	241,492	199,495	210.4 K to 199.5 K (-5.17 %)
Jan 31 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.20	369	8,192	376,986	377.4 K to 377 K (-0.10 %)
Jan 31 2020	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.20	2,673	59,341	2,730,057	2.7 M to 2.7 M (-0.10 %)
Dec 18 2019	CRNX	Crinetics Pharmace ...	Fust Matthew K	Director	Option Exercise	M	1.91	3,500	6,685	42,092
Dec 18 2019	CRNX	Crinetics Pharmace ...	Fust Matthew K	Director	Sell	S	22.50	3,500	78,750	12,536	16 K to 12.5 K (-21.83 %)
Dec 18 2019	CRNX	Crinetics Pharmace ...	Fust Matthew K	Director	Buy	M	1.91	3,500	6,685	16,036	12.5 K to 16 K (+27.92 %)
Aug 07 2019	CRNX	Crinetics Pharmace ...	Struthers Richard Scott	President & CEO	Option Exercise	M	1.91	10,000	19,100	172,370
Aug 07 2019	CRNX	Crinetics Pharmace ...	Struthers Richard Scott	President & CEO	Buy	M	1.91	10,000	19,100	1,225,805	1.2 M to 1.2 M (+0.82 %)
Aug 07 2019	CRNX	Crinetics Pharmace ...	Struthers Richard Scott	President & CEO	Gift	G	0.00	1,215,805	0	1,215,805	0 to 1.2 M
Aug 07 2019	CRNX	Crinetics Pharmace ...	Struthers Richard Scott	President & CEO	Gift	G	0.00	1,215,805	0	0	1.2 M to 0 (-100.00 %)
Jul 16 2019	CRNX	Crinetics Pharmace ...	Okey Stephanie	Director	Option Exercise	A	24.15	25,000	603,750	25,000
Jun 25 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.		Sell	S	22.20	10,000	222,000	94,489	104.5 K to 94.5 K (-9.57 %)
Jun 25 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.		Sell	S	22.20	240,000	5,328,000	2,267,797	2.5 M to 2.3 M (-9.57 %)
Jun 25 2019	CRNX	Crinetics Pharmace ...	Nichols Weston	Director	Option Exercise	A	23.24	12,500	290,500	12,500
Jun 25 2019	CRNX	Crinetics Pharmace ...	Nielsen Jack	Director	Option Exercise	A	23.24	12,500	290,500	12,500
Jun 25 2019	CRNX	Crinetics Pharmace ...	Fust Matthew K	Director	Option Exercise	A	23.24	12,500	290,500	12,500
Jun 25 2019	CRNX	Crinetics Pharmace ...	Kaldor Stephen W	Director	Option Exercise	A	23.24	12,500	290,500	12,500
Jun 25 2019	CRNX	Crinetics Pharmace ...	WIERENGA WENDALL	Director	Option Exercise	A	23.24	12,500	290,500	12,500
Mar 25 2019	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.25	83,984	1,868,644	210,373	294.4 K to 210.4 K (-28.53 %)
Mar 25 2019	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.25	40,407	899,056	377,355	417.8 K to 377.4 K (-9.67 %)
Mar 25 2019	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Sell	S	22.25	292,609	6,510,550	2,732,730	3 M to 2.7 M (-9.67 %)
Mar 20 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Sell	S	24.25	6,194	150,209	104,489	110.7 K to 104.5 K (-5.60 %)
Mar 20 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Sell	S	24.25	148,645	3,604,745	2,507,797	2.7 M to 2.5 M (-5.60 %)
Mar 12 2019	CRNX	Crinetics Pharmace ...	Struthers Richard Scott	President & CEO	Option Exercise	A	25.19	176,250	4,439,738	176,250
Mar 12 2019	CRNX	Crinetics Pharmace ...	Wilson Marc	Chief Financial Off ...	Option Exercise	A	25.19	56,250	1,416,938	56,250
Mar 12 2019	CRNX	Crinetics Pharmace ...	Krasner Alan Seth	Chief Medical Offic ...	Option Exercise	A	25.19	56,250	1,416,938	56,250
Feb 22 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	J	0.00	783	0	1,723	940 to 1.7 K (+83.30 %)
Feb 22 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	J	0.00	783	0	1,723	940 to 1.7 K (+83.30 %)
Feb 22 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	J	0.00	783	0	1,723	940 to 1.7 K (+83.30 %)
Feb 22 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	J	0.00	587	0	940	353 to 940 (+166.29 %)
Feb 22 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	J	0.00	353	0	353	0 to 353
Feb 22 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	J	0.00	940	0	940	0 to 940
Feb 22 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	J	0.00	940	0	940	0 to 940
Feb 22 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Sell	J	0.00	4,700	0	0	4.7 K to 0 (-100.00 %)
Feb 22 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	J	0.00	4,700	0	4,700	0 to 4.7 K
Feb 22 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Sell	J	0.00	18,800	0	110,683	129.5 K to 110.7 K (-14.52 %)
Feb 22 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Sell	J	0.00	451,200	0	2,656,442	3.1 M to 2.7 M (-14.52 %)
Feb 06 2019	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Sell	J	0.00	678	0	0	678 to 0 (-100.00 %)
Feb 06 2019	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	J	0.00	678	0	678	0 to 678
Feb 06 2019	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Sell	J	0.00	9,473	0	0	9.5 K to 0 (-100.00 %)
Feb 06 2019	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	J	0.00	9,473	0	9,473	0 to 9.5 K
Feb 06 2019	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Sell	J	0.00	33,903	0	192,122	226 K to 192.1 K (-15.00 %)
Feb 06 2019	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Sell	J	0.00	14,828	0	84,161	99 K to 84.2 K (-14.98 %)
Feb 06 2019	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Sell	J	0.00	13,387	0	75,949	89.3 K to 75.9 K (-14.99 %)
Feb 06 2019	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Sell	J	0.00	445,470	0	2,524,456	3 M to 2.5 M (-15.00 %)
Jan 24 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Sell	S	21.88	10,486	229,381	129,483	140 K to 129.5 K (-7.49 %)
Jan 24 2019	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Sell	S	21.88	251,667	5,505,216	3,107,642	3.4 M to 3.1 M (-7.49 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	61,861	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	383,507	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	1,484,690	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	9,204,220	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	P	17.00	4,600	78,200	139,969	135.4 K to 140 K (+3.40 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	P	17.00	110,400	1,876,800	3,359,309	3.2 M to 3.4 M (+3.40 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	C	0.00	18,802	0	135,369	116.6 K to 135.4 K (+16.13 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	C	0.00	116,567	0	116,567	0 to 116.6 K
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	C	0.00	451,274	0	3,248,909	2.8 M to 3.2 M (+16.13 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	C	0.00	2,797,635	0	2,797,635	0 to 2.8 M
Jul 20 2018	CRNX	Crinetics Pharmace ...	PERCEPTIVE ADVISORS LLC	Director	Option Exercise	C	0.00	6,186,205	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	PERCEPTIVE ADVISORS LLC	Director	Buy	P	17.00	400,000	6,800,000	2,280,305	1.9 M to 2.3 M (+21.27 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	PERCEPTIVE ADVISORS LLC	Director	Buy	C	0.00	1,880,305	0	1,880,305	0 to 1.9 M
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Option Exercise	C	0.00	187,648	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Option Exercise	C	0.00	1,358,903	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Option Exercise	C	0.00	1,163,311	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Option Exercise	C	0.00	8,424,416	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	P	20.73	153,180	3,175,421	294,357	141.2 K to 294.4 K (+108.50 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	P	17.00	141,177	2,400,009	141,177	0 to 141.2 K
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	P	17.00	7,137	121,329	417,762	410.6 K to 417.8 K (+1.74 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	P	17.00	51,686	878,662	3,025,339	3 M to 3 M (+1.74 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	C	0.00	57,035	0	410,625	353.6 K to 410.6 K (+16.13 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	C	0.00	413,040	0	2,973,653	2.6 M to 3 M (+16.13 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	C	0.00	353,590	0	353,590	0 to 353.6 K
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	C	0.00	2,560,613	0	2,560,613	0 to 2.6 M
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	103,293	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	45,192	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	40,826	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	1,357,240	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	640,332	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	280,485	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	253,091	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	8,413,817	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	31,396	0	226,025	194.6 K to 226 K (+16.13 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	13,736	0	98,989	85.3 K to 99 K (+16.11 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	12,409	0	89,336	76.9 K to 89.3 K (+16.13 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	412,534	0	2,969,926	2.6 M to 3 M (+16.13 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	194,629	0	194,629	0 to 194.6 K
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	85,253	0	85,253	0 to 85.3 K
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	76,927	0	76,927	0 to 76.9 K
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	2,557,392	0	2,557,392	0 to 2.6 M
Jul 20 2018	CRNX	Crinetics Pharmace ...	Krasner Alan Seth	Chief Medical Offic ...	Buy	P	17.00	2,000	34,000	2,000	0 to 2 K

Page: 1